EP Patent

EP3659307A4 — ANTI-CANCER MEDICINAL PRODUCTS AND THEIR MANUFACTURING AND USE PROCEDURES

Assigned to Yale University · Expires 2021-09-22 · 5y expired

What this patent protects

Patent listed against chembl-chembl112.

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

Patent Metadata

Patent number: EP3659307A4
Jurisdiction: EP
Classification: —
Expires: 2021-09-22
Drug substance claim: No
Drug product claim: No
Assignee: Yale University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.